Federal Appeals Court Hears Arguments on North Carolina Medication Abortion Rules

A federal appeals court in Richmond, Virginia, heard arguments concerning whether North Carolina can enforce additional restrictions and requirements on the medication mifepristone that were rejected by the Food and Drug Administration. The legal battle centers on a lawsuit filed in January 2023 challenging the state’s rules for patients seeking medication abortions.

A federal judge partially ruled on the case in 2024, permanently preventing the state from enforcing requirements for in-person prescribing, dispensing, administering, and follow-up appointments. However, that same judge upheld other requirements, including a 72-hour advance consultation, ultrasounds, in-person exams, blood testing, and adverse event reporting. The case has now moved to the Fourth Circuit, where arguments were presented by attorneys for both sides.

Arguments Over Federal Preemption and State Authority

Attorneys challenging the state rules argue that federal law preempts state regulations that conflict with and frustrate the objectives of federal law. They contend that allowing individual states to impose separate requirements on top of FDA decisions could create a confusing patchwork of safety regulations across the country for thousands of regulated drugs.

Conversely, legislative representatives defending the state argue that states maintain broad authority to regulate approved drugs and fill gaps in federal standards. They caution that blocking states from implementing additional safeguards could prevent them from protecting citizens or regulating high-risk drugs and opioids effectively.

What This Means for Patients and Providers

The outcome of this appeals court review could reshape how medication abortion is accessed and regulated in the state. Currently, abortion remains legal in North Carolina for any reason during the first 12 weeks of pregnancy, with specific exceptions up to 20 weeks or later under certain circumstances.

Patients and healthcare providers navigating these rules must continue following the current judicial arrangement while the appeals court considers whether to uphold, expand, or roll back the remaining state-level requirements. Because the litigation directly impacts healthcare delivery and drug access rules, individuals seeking care may want to verify current procedural requirements with their medical providers.

If you have questions about how changing regulations affect your healthcare rights or legal options, talking to a qualified attorney can help clarify your situation.

This article is general information based on Courthouse News Service and court or agency records available at publication time. It is not legal advice; laws and deadlines differ by state and by case. Published October 28, 2026.